Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival

被引:463
作者
Auvinen, P
Tammi, R
Parkkinen, J
Tammi, M
Ågren, U
Johansson, R
Hirvikoski, P
Eskelinen, M
Kosma, VM
机构
[1] Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Pathol, FIN-70211 Kuopio, Finland
[3] Kuopio Univ Hosp, Dept Surg, FIN-70211 Kuopio, Finland
[4] Univ Kuopio, Dept Anat, FIN-70211 Kuopio, Finland
[5] Univ Kuopio, Dept Pathol & Forens Med, FIN-70211 Kuopio, Finland
关键词
D O I
10.1016/S0002-9440(10)64757-8
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Hyaluronan (HA) is an extracellular matrix polysaccharide that promotes cell migration through its cell surface receptors and by effecting changes in the physical environment, HA expression is frequently increased in malignant tumors, whereas its association with the invasive potential and patient outcome in breast cancer has not been reported. The localization and signal intensity of HA. was analyzed in 143 paraffin-embedded tumor samples of human breast carcinoma using a biotinylated HA-specific probe. In the immediate peritumoral stroma, HA signal was moderately or strongly increased in 39% and 56% of the cases, respectively. Normal ductal epithelium showed no HE, whereas in 57% of the tumors at least some of the carcinoma cells were HA positive. The intensity of the stromal HA signal and the presence of cell-associated HA were both significantly related to poor differentiation of the tumors, axillary lymph node positivity, and short overall survival of the patients. In Cox's multivariate analysis, both the intensity of stromal HA signal alone and that combined with the HA positivity in tumor cells were independent prognostic factors for overall survival. These results suggest that HA is directly involved in the spreading of breast cancer and may offer a potential target for new therapies.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 49 条
[1]
CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]
Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO
[3]
2-0
[4]
INTERACTION BETWEEN CD44 AND HYALURONATE IS DIRECTLY IMPLICATED IN THE REGULATION OF TUMOR-DEVELOPMENT [J].
BARTOLAZZI, A ;
PEACH, R ;
ARUFFO, A ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :53-66
[5]
HYALURONIDASE ENHANCES THE ACTIVITY OF ADRIAMYCIN IN BREAST-CANCER MODELS INVITRO AND INVIVO [J].
BECKENLEHNER, K ;
BANNKE, S ;
SPRUSS, T ;
BERNHARDT, G ;
SCHONENBERGER, H ;
SCHIESS, W .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (08) :591-596
[6]
HYALURONAN (HYALURONIC-ACID) AND HYALURONECTIN IN THE EXTRACELLULAR-MATRIX OF HUMAN BREAST CARCINOMAS - COMPARISON BETWEEN INVASIVE AND NONINVASIVE AREAS [J].
BERTRAND, P ;
GIRARD, N ;
DELPECH, B ;
DUVAL, C ;
DANJOU, J ;
DAUCE, JP .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) :1-6
[7]
INCREASED HYALURONATE SYNTHESIS IS REQUIRED FOR FIBROBLAST DETACHMENT AND MITOSIS [J].
BRECHT, M ;
MAYER, U ;
SCHLOSSER, E ;
PREHM, P .
BIOCHEMICAL JOURNAL, 1986, 239 (02) :445-450
[8]
CEDENO D, 1986, J CELL BIOL, V103, pA101
[9]
Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[10]
BINDING AND DEGRADATION OF HYALURONAN BY HUMAN BREAST-CANCER CELL-LINES EXPRESSING DIFFERENT FORMS OF CD44 - CORRELATION WITH INVASIVE POTENTIAL [J].
CULTY, M ;
SHIZARI, M ;
THOMPSON, EW ;
UNDERHILL, CB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (02) :275-286